| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.78(B) |
| Last
Volume: |
311,626 |
Avg
Vol: |
491,839 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
4,793 |
4,793 |
27,311 |
85,518 |
| Total Sell Value |
$458,098 |
$458,098 |
$2,440,825 |
$6,945,164 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
4 |
4 |
10 |
25 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kroll Mark W |
Director |
• • – |
2018-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
27,459 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
4,605 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
2,997 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
28,459 |
|
- |
|
| Granadillo Pedro P |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
33,359 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
57,391 |
|
- |
|
| Burzik Catherine M |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
10,295 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
18,880 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,696 |
28,607 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2018-07-02 |
4 |
S |
$89.31 |
$458,964 |
D/D |
(5,139) |
133,126 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2018-06-25 |
4 |
AS |
$92.17 |
$616,341 |
D/D |
(6,687) |
14,604 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2018-06-25 |
4 |
OE |
$41.64 |
$238,056 |
D/D |
5,717 |
21,291 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
534 |
3,556 |
|
- |
|
| Bolorforosh Said |
EVP, Chief Technology Officer |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
935 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,673 |
13,270 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,606 |
15,574 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,470 |
6,253 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
11,361 |
138,265 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2018-06-08 |
4 |
AS |
$92.90 |
$53,696 |
D/D |
(578) |
3,022 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$39,410 |
D/D |
(425) |
12,968 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$16,970 |
D/D |
(183) |
15,226 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$19,844 |
D/D |
(214) |
4,783 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$42,378 |
D/D |
(457) |
10,597 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2018-06-07 |
4 |
AS |
$92.73 |
$7,511 |
D/D |
(81) |
3,600 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$179,989 |
D/D |
(1,941) |
126,904 |
|
- |
|
1354 Records found
|
|
Page 16 of 55 |
|
|
2.08 (2.18%) 
